Menu

• Ask a Health Expert about HAEMATOTOXICITY
• Post Your Side Effect related to HAEMATOTOXICITY
• HAEMATOTOXICITY and FDA Warnings
• HAEMATOTOXICITY in Patients Wiki
• Report HAEMATOTOXICITY in Drug Side Effect Survey

HAEMATOTOXICITY side effect

What is HAEMATOTOXICITY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Carboplatin Side Effects Report #5580150-7
Health Professional from UNITED STATES reported CARBOPLATIN problem on Dec 27, 2007. Female patient, weighting 168.9 lb, was diagnosed with fallopian tube cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, neutropenia, thrombocytopenia, . CARBOPLATIN dosage: 737 MG, IV Q 3 WEEKS. During the same period patient was treated with PACLITAXEL, DASATINIB, ONDANSETRON, MIRALAX. Patient recovered.

Gleevec Side Effects Report #5653920-4
GLEEVEC problem was reported by a Physician from SPAIN on Feb 27, 2008. Female patient, 44 years of age, weighting 134.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, leukopenia, thrombocytopenia, . GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with VINCRISTINE, DAUNORUBICIN, MITOXANTRONE, CITARABINA, METHOTREXATE, HYDROCORTISONE, IRRADIATION. Patient was hospitalized. Patient recovered.

Valproate Side Effects Report #5685136-X
Consumer or non-health professional from TURKEY reported VALPROATE problem on Mar 18, 2008. Male patient, 38 years of age, was diagnosed with bipolar i disorder and was treated with VALPROATE. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, hepatotoxicity, . VALPROATE dosage: unknown. During the same period patient was treated with OLANZAPINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5634402-2
GEMZAR problem was reported by a Physician from CZECH REPUBLIC on Feb 12, 2008. Male patient was diagnosed with germ cell cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, neurotoxicity, . GEMZAR dosage: 1000 MG/M2, DAY 1 AND 5 OF 3-4 WEEK CYCLES. During the same period patient was treated with PACLITAXEL. Patient recovered.


Gemzar Side Effects Report #5636365-2
Physician from CZECH REPUBLIC reported GEMZAR problem on Feb 12, 2008. Male patient was diagnosed with germ cell cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, ototoxicity, . GEMZAR dosage: 1000 MG/M2, DAY 1 AND 5 OF 3-4 WEEK CYCLES. During the same period patient was treated with PACLITAXEL. Patient recovered.

Zevalin Side Effects Report #5600986-3
ZEVALIN problem was reported by a Physician from ITALY on Jan 04, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, hepatic failure, hepatotoxicity, neutropenia, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXIMAB, ANTIBIOTIC PROPHYLAXIS. Patient recovered.

Zevalin Side Effects Report #5613320-X
Physician from GERMANY reported ZEVALIN problem on Jan 21, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, hepatotoxicity, neutropenia, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient recovered.

Cisplatin Side Effects Report #5570572-2
CISPLATIN problem was reported by a Health Professional from JAPAN on Dec 18, 2007. Female patient was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, infection, nephropathy toxic, pulmonary toxicity, stomatitis, . CISPLATIN dosage: unknown. During the same period patient was treated with BLEOMYCIN, METHOTREXATE, LEUCOVORIN CALCIUM. Patient recovered.

Carboplatin Side Effects Report #5580150-7
Health Professional from UNITED STATES reported CARBOPLATIN problem on Dec 27, 2007. Female patient, weighting 168.9 lb, was diagnosed with fallopian tube cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, neutropenia, thrombocytopenia, . CARBOPLATIN dosage: 737 MG, IV Q 3 WEEKS. During the same period patient was treated with PACLITAXEL, DASATINIB, ONDANSETRON, MIRALAX. Patient recovered.


Ifosfamide Side Effects Report #5452623-9
IFOSFAMIDE problem was reported by a Consumer or non-health professional from SWITZERLAND on Sept 12, 2007. Female patient was diagnosed with sarcoma and was treated with IFOSFAMIDE. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, . IFOSFAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, MESNA, GRANULOCYTE CSF. Patient recovered.

Rituxan Side Effects Report #5409024-9
Physician from UNITED KINGDOM reported RITUXAN problem on July 31, 2007. Female patient, weighting 136.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, . RITUXAN dosage: 640 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, NEUPOGEN. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5427877-5
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Aug 20, 2007. Female patient, weighting 136.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, . RITUXIMAB dosage: 640 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, NEUPOGEN. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5428310-X
Physician from FRANCE reported TEMODAL problem on Aug 16, 2007. Female patient was diagnosed with central nervous system lymphoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, septic shock, . TEMODAL dosage: 150 MG/M2; QD; PO. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5429885-7
TEMODAL problem was reported by a Physician from FRANCE on Aug 22, 2007. Female patient, 74 years of age, weighting 152.1 lb, was diagnosed with lymphoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, hypotension, respiratory failure, septic shock, . TEMODAL dosage: 270 MG; QD; PO. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #5401309-5
Physician from UNITED KINGDOM reported RITUXAN problem on July 23, 2007. Female patient, weighting 136.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, . RITUXAN dosage: 640 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5401309-5
RITUXAN problem was reported by a Physician from UNITED KINGDOM on July 23, 2007. Female patient, weighting 136.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, . RITUXAN dosage: 640 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.

Tasigna Side Effects Report #5763588-4
Health Professional from GERMANY reported TASIGNA problem on May 30, 2008. Female patient was diagnosed with chronic myeloid leukaemia and was treated with TASIGNA. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, haemoglobin decreased, leukopenia, neutropenia, red blood cell count decreased, thrombocytopenia, . TASIGNA dosage: unknown. Patient recovered.

Thalomid Side Effects Report #5706378-0
THALOMID problem was reported by a Physician from UNITED STATES on Apr 01, 2008. Female patient was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, infection, lymphopenia, neutropenia, palmar-plantar erythrodysaesthesia syndrome, . THALOMID dosage: 200 MG, DAILY, ORAL. During the same period patient was treated with BORTEZOMIB, LIPOSOMAL DOXORUBICIN, ACLOVIR, WARFARIN. Patient recovered.

Bevacizumab Side Effects Report #5708046-8
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Apr 02, 2008. Female patient was diagnosed with rectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, tumour haemorrhage, . BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.


Temozolomide Side Effects Report #5324583-2
TEMOZOLOMIDE problem was reported by a Physician from TURKEY on May 04, 2007. Male patient, 44 years of age, weighting 158.7 lb, was diagnosed with malignant glioma and was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, headache, neutropenia, rash, thrombocytopenia, . TEMOZOLOMIDE dosage: 180 MG;QD;PO. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE. Patient died on 02/24/2007.

Temozolomide Side Effects Report #5261417-9
Physician from TURKEY reported TEMOZOLOMIDE problem on Feb 28, 2007. Male patient, 44 years of age, weighting 158.7 lb, was diagnosed with malignant glioma and was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, headache, neutropenia, rash, thrombocytopenia, white blood cell count decreased, . TEMOZOLOMIDE dosage: 180 MG;QD;PO. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE. Patient died on 02/24/2007.

Topotecan Side Effects Report #5603239-2
TOPOTECAN HYDROCHLORIDE STERILE problem was reported by a Consumer or non-health professional from GERMANY on Jan 08, 2008. Male patient, child 6 years of age, was diagnosed with brain neoplasm and was treated with TOPOTECAN HYDROCHLORIDE STERILE. After drug was administered, patient experienced the following problems/side effects: dermatitis, haematotoxicity, palmar-plantar erythrodysaesthesia syndrome, stomatitis, vomiting, . TOPOTECAN HYDROCHLORIDE STERILE dosage: 3 MG/M2 /TWICE PER DAY / ORAL. During the same period patient was treated with DOXORUBICIN. Patient recovered.

Zevalin Side Effects Report #5613319-3
Physician from GERMANY reported ZEVALIN problem on Jan 21, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, hepatic failure, hepatotoxicity, neutropenia, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXIMAB, ANTIBIOTIC PROPHYLAXIS. Patient recovered.

Velcade Side Effects Report #5615407-4
VELCADE problem was reported by a Physician from SPAIN on Jan 22, 2008. Female patient, 61 years of age, weighting 213.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: ear pain, haematotoxicity, pancytopenia, pyrexia, respiratory disorder, . VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5558013-2
Physician from FRANCE reported TEMODAL problem on Dec 04, 2007. Female patient, 73 years of age, weighting 143.3 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, haematotoxicity, hypokalaemia, . TEMODAL dosage: 150 MG/M2;QD;PO; 340 MG;QD;PO. During the same period patient was treated with LEVOTHYROX, PANTOPRAZOLEE, RYTHMOL, INDAPAMIDE, TANAKAN, ZOPICLONE, DIAMICRON. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5507757-7
REVLIMID problem was reported by a Health Professional from GERMANY on Oct 23, 2007. Male patient, 65 years of age, weighting 132.3 lb, was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, monoclonal immunoglobulin present, retinal vein occlusion, thrombocytopenia, venous thrombosis, . REVLIMID dosage: 25 MG, DAILY, ORAL; 15 MG, DAILY, ORAL. During the same period patient was treated with NEULASTA, OCTAGAM, AVELOX, GAMUNEX, ERYTHROCYTES CONCENTRATE, THROMBOCYTES CONCENTRATE, ARANESP. Patient recovered.

Natalizumab Side Effects Report #5519614-0
Health Professional from UNITED STATES reported NATALIZUMAB problem on Nov 06, 2007. Female patient, weighting 126.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, international normalised ratio increased, multiple sclerosis relapse, prothrombin time prolonged, sepsis, staphylococcal infection, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

Amiodarone Side Effects Report #5531358-8
AMIODARONE problem was reported by a Consumer or non-health professional from CANADA on Nov 12, 2007. Male patient, 80 years of age, was diagnosed with sick sinus syndrome and was treated with AMIODARONE. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, pancytopenia, pulmonary hypertension, . AMIODARONE dosage: unknown. Patient was hospitalized. Patient recovered.

Ifosfamide Side Effects Report #5452647-1
Consumer or non-health professional from UNITED STATES reported IFOSFAMIDE problem on Sept 10, 2007. Female patient was diagnosed with squamous cell carcinoma and was treated with IFOSFAMIDE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal toxicity, haematotoxicity, . IFOSFAMIDE dosage: FIXED DOSES OF IFOSFAMIDE (1200MG/M2) WITH MESNA WAS ADMINISTERED ON DAYS 1 TO 4.. During the same period patient was treated with CISPLATIN, MESNA, DOCETAXEL, CAPECITABINE. Patient recovered.

Natalizumab Side Effects Report #5463790-5
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Sept 06, 2007. Female patient, 49 years of age, weighting 126.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, international normalised ratio increased, prothrombin time prolonged, staphylococcal infection, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.

Pyrimethamine Side Effects Report #5466832-6
Consumer or non-health professional from SPAIN reported PYRIMETHAMINE problem on Sept 07, 2007. Female patient, 37 years of age, was diagnosed with cerebral toxoplasmosis and was treated with PYRIMETHAMINE. After drug was administered, patient experienced the following problems/side effects: anaemia, haematotoxicity, leukopenia, . PYRIMETHAMINE dosage: unknown. During the same period patient was treated with SULPHADIAZINE, PROPRANOLOL HYDROCHLORIDE. Patient recovered.

Hycamtin Side Effects Report #5384220-8
HYCAMTIN problem was reported by a Physician from GERMANY on July 09, 2007. Female patient, 71 years of age, weighting 196.2 lb, was diagnosed with cervix carcinoma and was treated with HYCAMTIN. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, haematotoxicity, renal failure, . HYCAMTIN dosage: unknown. During the same period patient was treated with ALLOPURINOL, TORSEMIDE. Patient was hospitalized. Patient recovered.

Hycamtin Side Effects Report #5384220-8
Physician from GERMANY reported HYCAMTIN problem on July 09, 2007. Female patient, 71 years of age, weighting 196.2 lb, was diagnosed with cervix carcinoma and was treated with HYCAMTIN. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, haematotoxicity, renal failure, . HYCAMTIN dosage: unknown. During the same period patient was treated with ALLOPURINOL, TORSEMIDE. Patient was hospitalized. Patient recovered.

Zevalin Side Effects Report #5762146-5
ZEVALIN problem was reported by a Health Professional from GERMANY on May 20, 2008. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: catheter related infection, haematotoxicity, pseudomonas infection, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXIMAB, INTERFERON ALPHA. Patient recovered.

Temodal Side Effects Report #5732106-9
Physician from AUSTRALIA reported TEMODAL problem on Apr 28, 2008. Male patient, 46 years of age, weighting 154.3 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haematotoxicity, infection, inflammation, macrocytosis, mean cell haemoglobin increased, pneumocystis jiroveci pneumonia, red blood cell count decreased, thrombocytopenia, . TEMODAL dosage: 340 MG; PO. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, SIMVASTATIN, VALPROIC ACID. Patient was hospitalized. Patient recovered.

Thalomid Side Effects Report #5705215-8
THALOMID problem was reported by a Physician from ITALY on Apr 01, 2008. Female patient was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, haematotoxicity, hepatic function abnormal, neurotoxicity, . THALOMID dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with INTERFERON, DEXAMETHASONE. Patient recovered.

Doxorubicin Side Effects Report #5324841-1
Physician from SWITZERLAND reported DOXORUBICIN problem on May 10, 2007. Female patient, weighting 108.0 lb, was diagnosed with breast cancer metastatic and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: asthenia, haematotoxicity, haemoglobin decreased, leukopenia, neutropenia, pulmonary embolism, . DOXORUBICIN dosage: unknown. Patient died on 03/07/2006.

Mabthera Side Effects Report #5281330-0
MABTHERA problem was reported by a Physician from SWITZERLAND on Mar 14, 2007. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, multi-organ failure, platelet count decreased, septic shock, white blood cell count decreased, . MABTHERA dosage: 700 MG. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 09/01/2005.

Temodal Side Effects Report #5676575-1
Physician from FRANCE reported TEMODAL problem on Mar 11, 2008. Female patient, 73 years of age, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile bone marrow aplasia, haematotoxicity, hypokalaemia, mouth haemorrhage, oropharyngeal blistering, purpura, . TEMODAL dosage: 150 MG/M2 QD PO ; 340 MG QD PO ; 255 MG QD PO ; PO. During the same period patient was treated with LEVOTHYROXINE, PANTOPRAZOLE, RYTHMOL, INDAPAMIDE, TANAKAN. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5678056-8
CLOFARABINE problem was reported by a Health Professional from UNITED STATES on Mar 24, 2008. Female patient, 65 years of age, weighting 148.4 lb, was diagnosed with lymphoma and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, haematotoxicity, neutropenia, renal failure, thrombocytopenia, . CLOFARABINE dosage: 4MG/M2 QD X 5 DAYS IV 3 MG/M2 QD X 5 DAYS IV. Patient was hospitalized. Patient recovered.

Doxepin Side Effects Report #5584848-6
Consumer or non-health professional from UNITED STATES reported DOXEPIN problem on Dec 21, 2007. Female patient, 40 years of age, was diagnosed with depression and was treated with DOXEPIN. After drug was administered, patient experienced the following problems/side effects: alcohol use, haematotoxicity, . DOXEPIN dosage: unknown. During the same period patient was treated with AMPHETAMINE, CANNABIS, BENZODIAZEPINE. Patient died.

Zevalin Side Effects Report #5613324-7
ZEVALIN problem was reported by a Physician from ITALY on Jan 21, 2008. Female patient was diagnosed with b-cell lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haematotoxicity, hepatic failure, hepatitis c virus, hepatotoxicity, myelodysplastic syndrome, platelet count decreased, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient recovered.

Navelbine Side Effects Report #5528997-7
Consumer or non-health professional from ITALY reported NAVELBINE problem on Oct 29, 2007. Female patient, 76 years of age, was diagnosed with breast cancer metastatic and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: anaemia, disease progression, haematotoxicity, thrombocytopenia, transient ischaemic attack, . NAVELBINE dosage: 50 MG/M2 IV. During the same period patient was treated with GEMCITABINE. Patient recovered.

Gliadel Side Effects Report #5475337-8
GLIADEL problem was reported by a Physician from UNITED STATES on Apr 18, 2007. Female patient was diagnosed with malignant glioma and was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: disease progression, haematotoxicity, neurotoxicity, neutropenia, pancytopenia, thrombocytopenia, wound infection, . GLIADEL dosage: unknown. During the same period patient was treated with TEMOZOLOMIDE. Patient recovered.

Cetuximab Side Effects Report #5482228-5
Physician from UNITED STATES reported CETUXIMAB problem on Oct 09, 2007. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with neoplasm malignant and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: epiglottic erythema, epiglottic oedema, haematotoxicity, . CETUXIMAB dosage: 450 MG/M2 ON 5/18/2007.. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5501369-7
PROGRAF problem was reported by a Health Professional from FRANCE on Oct 10, 2007. Female patient, child 5 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, bone marrow failure, haematotoxicity, . PROGRAF dosage: 1.4 MG, BID, ORAL. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5447437-X
Health Professional from FRANCE reported PROGRAF problem on Aug 20, 2007. Female patient, child 5 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, bone marrow failure, haematotoxicity, . PROGRAF dosage: 1.4 MG, BID, ORAL. During the same period patient was treated with CELLCEPT, ASPIRIN. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5407590-0
REVLIMID problem was reported by a Physician from UNITED STATES on July 25, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: embolism, febrile neutropenia, haematotoxicity, thrombocytopenia, vasculitis, . REVLIMID dosage: 10 MG, QD X21 DAYS, ORAL. During the same period patient was treated with DEXAMETHASONE, MELPHALAN, PREDNISONE, BORTEZOMIB, ASPIRIN. Patient recovered.

Revlimid Side Effects Report #5786291-3
Health Professional from GERMANY reported REVLIMID problem on June 10, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, embolism, haematotoxicity, infection, neutropenia, . REVLIMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient died.

Sprycel Side Effects Report #5787982-0
SPRYCEL problem was reported by a Consumer or non-health professional from UKRAINE on June 20, 2008. Female patient, 30 years of age, was diagnosed with chronic myeloid leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: constipation, gastric haemorrhage, haematotoxicity, . SPRYCEL dosage: INTER:14JAN-RESTAST29JAN140MG;8FEB;70MG 9-28FEBINRPT 29FEB-13MAR70MG 14MAR-21APR100MG 22APR-5MAY08. Patient died on 06/16/2008.

Decitabine Side Effects Report #5730782-8
Physician from UNITED STATES reported DECITABINE problem on Apr 21, 2008. Female patient was diagnosed with myelodysplastic syndrome and was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile neutropenia, haematotoxicity, hepatic enzyme increased, hypokalaemia, pancytopenia, syncope, . DECITABINE dosage: 20 MG/M2, IN 1 DAY, INTRAVENOUS. Patient recovered.